Info
13F
Schedule 13D
Ownership

Deerfield Management Company, L.P. (Series C) - Significant Ownership

Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Deerfield Management Company, L.P. (Series C).

Significant Ownership of Deerfield Management Company, L.P. (Series C)

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
SPRY	ARS Pharmaceuticals, Inc.	Common Stock, par value $0.0001 per share	10.72%	$154M		10.5M		Deerfield Management Company, L.P.	Mar 20, 2025
PHGE	BiomX Inc.	Common Stock, par value $0.0001 per share	9.99%	$2.18M		15.6M		Deerfield Management Company, L.P.	Feb 27, 2025

Showing 1 to 2 of 2 entries

Schedules 13D/G Reported by Deerfield Management Company, L.P. (Series C):

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.